Pfizer to Fight Against Canadian Firm's Anti-cholesterol Drug

by VR Sreeraman on  January 4, 2008 at 5:28 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Pfizer to Fight Against Canadian Firm's Anti-cholesterol Drug
US drug giant Pfizer said Thursday it will appeal a Canadian federal court decision paving the way for the pharmaceutical firm Apotex to launch a generic version of its anti-cholesterol drug Lipitor.

The court had previously denied Pfizer's request to prevent Apotex from launching a generic version of Lipitor prior to the expiration of a Pfizer patent in July 2010.

The drug (atorvastatin calcium) has generated 13 billion dollars in sales worldwide for Pfizer, making it the leading cholesterol-lowering medication.

Lipitor is used to treat high cholesterol, helping to prevent heart disease and hardening of the arteries -- conditions that can lead to heart attack, stroke, and vascular disease.

Pfizer said the Canadian court's decision "has no immediate commercial impact because Lipitor is protected by other patents in Canada, which also are the subject of pending legal challenges."

The ruling by the federal court also has no impact on Lipitor patent litigation in other countries, the company said.

Source: AFP
LIN/M

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Top Ten Selling Drugs 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive